Anti-aging
FOXO4-DRI
The headline senolytic peptide. It disrupts the FOXO4-p53 interaction inside senescent cells, pushing them into apoptosis while sparing healthy cells. Striking in mice, untested in humans.
€369.99per vial
Choose an option
1
- Pay with Bitcoin
- Discreet shipping within Germany
- Purity-guaranteed batches
- 14-day refund period if unsatisfied
Delivery & guarantee
Orders typically arrive within 3 weeks.
If your delivery arrives late, you'll receive a discount on your next order.
About
FOXO4-DRI sits at the most ambitious end of the longevity catalogue. The 2017 de Keizer paper showed that aged mice given the peptide regrew fur, lost frailty markers, and recovered kidney function.
Read the full research guideWhy people choose it
- Selectively triggers apoptosis in senescent ("zombie") cells that resist normal cell death. Mechanism validated in vitro and in rodents
- Reduces senescence-associated inflammation in animal models. The chronic low-grade kind implicated in aging
- Rodent studies show fur regrowth, frailty reversal, and improved tissue function. Striking but unreplicated outside the original group at scale
- Pulsed protocol means lower total drug exposure than daily peptides. A feature, given the unknowns
At a glance
- Experience level
- Advanced
- Administration
- Subcutaneous
Sold for laboratory research only. Not for human consumption. No therapeutic claims are made.
Sign in to view this product
FOXO4-DRI
Log in or create a free account to see full details and prices.
Don't have an account? Sign up